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BACKGROUND: Current guidelines for screening for HIV infections in Nova Scotia recommend an opt-in approach in which patients are counselled and consent to testing. The objectives of the present study were to measure adherence to these recommendations, to explore women's knowledge, attitudes, beliefs and behaviours concerning HIV screening, and to compare these results with prenatal screening practices for rubella, hepatitis B and group B streptococcus. METHODS: All women who gave birth consecutively during a sevenweek period were recruited. Study participants were interviewed to determine their knowledge, attitudes and beliefs concerning prenatal screening. Hospital and laboratory records were reviewed for information concerning prenatal screening and perinatal treatment to audit screening practices. RESULTS: A total of 279 patients were enrolled in the study, representing 58% of those eligible. The HIV screening rate was 72%, compared with 95% for rubella, 89% for hepatitis B and 24% for group B streptococcus. Of the participants tested for HIV, 80% were aware of being tested. Of all the study participants, 17% indicated having received pretest counselling about HIV, 56% volunteered to be tested for HIV, 78% received the test results, and 3.8% received post-test counselling. More participants preferred an opt-out approach to HIV screening (50%), where testing is routinely performed on everyone, rather than the opt-in approach (43%). Participants displayed a similar preference for screening for the other infections. INTERPRETATION: HIV prenatal testing rates in Nova Scotia are comparable with those of other provinces that recommend an opt-in approach, but are lower than testing rates for opt-out programs. Most study participants were not screened using the recommended opt-in approach. H uman immunodeficiency virus can be transmitted from a mother to her infant during pregnancy (1-3), during delivery (4) or through breastfeeding (5) ; the risk of transmission generally ranges from 15% to 30% (6) (7) (8) (9) . Antiretroviral therapy during pregnancy has been shown to be effective in reducing the rate of vertical transmission of HIV (10) . There has been much debate surrounding HIV prenatal screening, as the benefits of treatment must be weighed against the dangers of disregarding patient autonomy (11) .
The Reproductive Care Program of Nova Scotia recommends that an opt-in approach be used with all women during prenatal screening, whereby every woman receives HIV counselling, consents specifically to HIV testing, and is counselled after testing (12) . Some jurisdictions (Newfoundland, Alberta and the Northwest Territories) use an opt-out approach, whereby all women are tested unless they specifically refuse testing (13) .
The purpose of the present study was to audit the prenatal screening practices for HIV at the IWK Health Centre, the tertiary care hospital for obstetrics and pediatrics in Nova Scotia. We also compared these results with screening programs for other infections that use different approaches, namely, rubella, hepatitis B and group B streptococcus (GBS). Tests for rubella and hepatitis B are both universal screening programs in Nova Scotia and are performed at the same time as HIV testing, using the same requisition form; therefore, these programs provide a useful basis for comparing the opt-in approach. Finally, we explored postpartum women's experiences, knowledge, attitudes and beliefs concerning screening for HIV and compared these results with those of the other screening programs.
METHODS
The present study was performed at the IWK Health Centre, which provides perinatal care for the Halifax Regional Municipality in Nova Scotia (population 380,000). The IWK Health Centre was responsible for 55% of live births in Nova Scotia in 2004 and therefore provides a good representation of perinatal care in Nova Scotia. All mothers who gave birth to a live infant at the IWK Health Centre during a seven-week period (July 12, 2004, to August 23, 2004) were offered enrollment in the study the day after delivery. Exclusion criteria included having an infant in the neonatal intensive care unit or not being able to speak English. Eligible women were given a letter of introduction explaining the nature and the purpose of the study. Consenting study participants were interviewed by one of two medical students using a survey specifically designed for the study. Interviews were conducted within 48 h of delivery. After completion of the survey, all participants were given information sheets regarding the infections discussed in the survey. The study was approved by the Research Ethics Boards of the IWK Health Centre and the Queen Elizabeth II Health Sciences Centre.
The survey consisted of 65 questions and was administered during a 15 min interview. Before study initiation, the survey was pilot-tested by two focus groups and subsequently modified. The first group, comprising four postpartum mothers one day after their delivery, evaluated the survey for clarity and ease of completion. The second group, comprising five infectious disease specialists, used a content validity index to evaluate the survey. Interviewers were specifically trained in interviewing techniques. Participants were questioned on a number of demographic variables, including age, education, ethnic origin, number of pregnancies and deliveries, attendance at prenatal classes, type of care provider and area of prenatal care. Study participants were asked whether they had undergone prenatal screening and counselling for hepatitis B, HIV, GBS and rubella. Questions were also asked about experiences with prenatal testing and attitudes toward screening protocols.
The IWK Health Centre laboratory database and health records were reviewed for laboratory results concerning prenatal testing. Acceptable screening tests included a rubella antibody titre performed any time during or before the pregnancy, hepatitis B surface antigen serology performed any time during or before pregnancy, HIV antibody serology performed any time during pregnancy, and GBS cultures from vaginal-rectal swabs taken at 35 to 37 weeks gestation. In addition, charts were examined for documentation of pretest counselling for HIV. Laboratory results from participants who had incomplete information after chart review were sought from a list of test results that were provided from the Queen Elizabeth II Health Sciences Centre, the only other hospital providing prenatal laboratory testing in the Halifax Regional Municipality. If participants indicated that they received all of their prenatal care in the Halifax Regional Municipality but a test result was not found at either of these two hospitals, then it was assumed the test was not performed. To identify tests that were performed outside of Halifax, family doctors were contacted to provide any remaining information.
Binomial point estimates and exact binomial confidence intervals were used to summarize proportions. Fisher's exact test, the Fisher-Freeman-Halton test or Monte Carlo estimates were used to compare demographic variables with survey questions and chart review results. Fisher's exact test was used to compare screening preferences across infection types. Results were considered significant at P<0.05. A sample size of 271 was calculated to ensure a 95% CI half width of 5% for the point estimates.
RESULTS
Of 484 eligible women, 279 (58%) consented to take part in the study. Seventy-six of the 205 nonparticipants were discharged from hospital before they could be approached for consent; the remaining 129 women declined to meet with the investigators. All 279 study participants completed interviews. After laboratory and health records were reviewed, and family physicians contacted, the following information remained missing: one participant had an unknown rubella immunity status; six participants had an unknown status for GBS testing; and one participant had an unknown status for hepatitis B surface antigen serology. Whether or not the prenatal care provider ordered HIV testing was determined for all participants.
Most participants received all of their prenatal care in the Halifax Regional Municipality (Table 1) . Most participants were 25 to 34 years of age, had a postsecondary degree and were primiparous. A similar number of participants was followed by family doctors and obstetricians. Demographic characteristics were similar among those who received all their care in the Halifax Regional Municipality and all study participants.
The HIV testing rate was 72.0% (95% CI 66.4 to 77.2). Rubella and hepatitis B testing levels (the two universal screening programs) were 95.0% (95% CI 91.7 to 97.2) and 89.2% (95% CI 85.0 to 92.6), respectively. GBS testing levels were the lowest at 24.0% (95% CI 19.1 to 29.5). This was expected because both GBS testing and screening by risk factor were acceptable practices at the time the study was undertaken.
The proportion of participants who were aware of being tested for HIV was 80.1% (95% CI 73.9 to 85.4). Fewer participants were aware of being tested for hepatitis B (39.0%; 95% CI 32.9 to 45.3) and rubella (50.6%; 95% CI 44.4 to 56.7), which would be expected considering these tests are part of routine prenatal blood work. Participants were most aware of being tested for GBS (83.6%; 95% CI 71.2 to 92.2), which was also to be expected because this test is much more invasive and would have been done relatively close to delivery.
The proportion of study participants who indicated that they received pretest counselling for HIV testing was 17.4% (95% CI 13.1 to 22.4) ( Table 2) . A similar proportion of patients underwent documented HIV counselling (17.9%; 95% CI 13.6 to 22.9). Of the participants who indicated that they were tested, only 56.3% (95% CI 48.9 to 63.6) indicated that they had given specific consent to HIV testing. After HIV testing, 78.4% (95% CI 71.9 to 84.0) of participants who were tested received their test results, and only 3.8% (95% CI 1.6 to 7.7) who were tested received post-test counselling. Study participants who were not tested were asked to give reasons for not being tested. The majority indicated that they were not tested because they were not offered the test (62.1%). Other reasons for not receiving HIV testing included having already been tested before the pregnancy (24.1%) and not believing to be at risk for having an HIV infection (5.2%).
Study participants were also asked about how they thought HIV prenatal screening should be performed. The options given were routine testing for everyone, offering the test to everyone, routine testing of high-risk individuals only, and offering the test to high-risk individuals only. Routine testing for everyone is referred to in the literature as the opt-out approach, whereas offering the test to everyone is referred to as the opt-in approach. One-half of the study participants chose the opt-out approach as their preferred method of screening, whereas 42.8% chose the opt-in approach. There were no significant differences between these preferences and the preferences for prenatal screening of rubella, hepatitis B and GBS. Participants who chose the opt-out approach also indicated whether they would want HIV counselling before testing. The majority (76.3%) indicated that they would want HIV counselling, demonstrating that, overall, most participants would want HIV counselling regardless of whether the screening was opt-in or opt-out.
There were no differences in survey responses or HIV testing rates based on age, number of pregnancies or attendance at prenatal classes. All women who had less than a high school education were given their test results, whereas the women with higher levels of education less commonly received their test results (61% to 80%; P=0.049). There were no significant differences based on whether the primary health care provider was a family physician or an obstetrician. Finally, results were compared between those who received all of their care in the Halifax Regional Municipality and those who received all of their care in rural Nova Scotia (mainland Nova Scotia and Cape Breton). The only significant difference was in the documentation of HIV pretest counselling: 17% of participants had documented HIV counselling in Halifax, whereas 29% of participants had documented HIV counselling in rural Nova Scotia (P=0.0012). they were counselled after testing
DISCUSSION
The present study found the prenatal testing rate for our group of participants to be 72%. This is a significant improvement over the rate of 45% that was reported in 2000 at the same centre (14) . A substantial proportion of women are still not receiving testing. The prenatal testing rate for HIV in Nova Scotia is comparable with that of other provinces that use an opt-in approach, but is lower than in provinces that use an opt-out approach. Ontario and British Columbia both use an opt-in approach and have reported testing rates of 72% and 76%, respectively (15, 16) . Alberta and Newfoundland have adopted an opt-out approach and have much higher testing rates, at 98% and 94%, respectively (17, 18) .
Our results also indicate that there are deficiencies in the HIV counselling process in Nova Scotia. Relatively few women received pretest and post-test counselling, a large number of study participants did not consent to the test, a significant number of women were not aware of being tested, and most women who were not tested were not offered the test. Mechanisms need to be put into place to ensure that women receive proper HIV counselling during pregnancy. Currently, resources are not available for physicians to do this routinely during prenatal appointments. Further exploration is required to determine whether physicians are willing and able to provide counselling if resources were available. Innovative methods for providing women with information regarding HIV testing must be developed to allow more women the opportunity to obtain HIV testing in a consensual fashion. This may include resources such as written information that patients may read before their appointment, or trained individuals who can provide counselling outside of prenatal visits.
Attitudes about HIV screening have been gradually shifting in favour of the opt-out approach, which produces higher testing frequencies. The low rates of counselling and consent to testing in the present study may indicate that some physicians are using an opt-out approach for HIV screening. The major concern with the opt-out approach is that the number of women who receive HIV counselling could decrease. There could be grave implications for a woman who tests positive for HIV, including, for example, depression, social isolation and discrimination. These problems could escalate if appropriate pretest and post-test counselling is not undertaken.
There are several limitations to the present study. Because the acceptance rate was 58% and demographic information was not obtainable from patients not enrolled in the study, the results may not be generalizable to the entire population in Halifax or Nova Scotia. For instance, 16% of eligible women were discharged from hospital before they could be approached by the investigators; this group could have represented those with the lowest risks at childbirth. The participants who were enrolled primarily represented an urban population with high levels of postsecondary education. HIV screening in more rural areas may present a different picture; we did find a higher rate of documentation of counselling in rural Nova Scotia than in urban Nova Scotia. Finally, no participants in the study tested positive for HIV. There has been only one study (19) estimating the prevalence of HIV infection during pregnancy; only one case was identified among almost 15,000 pregnant women. Therefore, it was expected that we would not have any subjects in our study with HIVpositive serology. Nonetheless, HIV-positive individuals may have different attitudes toward prenatal HIV screening compared with the subjects in the present study.
Another limitation of the study is that participants were asked to recall events that happened early in the pregnancy; hence, there may be a significant element of recall bias in their survey responses. Undoubtedly, women do not remember all of the details of their prenatal care visits; however, counselling in the present study was considered to be any form of discussion about HIV testing. Guidelines for counselling for HIV testing involve providing information about the infection, risk factors, testing options, confidentiality and the implications of results (20) . If participants could not recall the counselling they received about HIV or whether they were tested, then the counselling may have been inadequate.
In conclusion, the findings from our study indicate that HIV testing rates are relatively low during pregnancy, and that HIV counselling is often inadequate. Testing rates may be improved by an opt-out approach, as only those provinces with such an approach have been able to reach rates greater than 90%. If an opt-out approach were to be adopted, a mechanism would need to be established to ensure that HIV counselling takes place before testing. HIV counselling is an ethical obligation that prepares the patient for the serious consequences that could result from a positive test.
